Economic Evaluation of Letrozole for Early Breast Cancer in a Health Resource-Limited Setting

OBJECTIVE: Long-term aromatase inhibitor (AI) therapy is expected to improve the health outcomes with high health resource consumption in early breast cancer. The aim of the study was to assess the cost-effectiveness of letrozole for postmenopausal women with estrogen receptor positive early breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Ming, Lu, Jingsong, Yang, Fan, Wu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098874/
https://www.ncbi.nlm.nih.gov/pubmed/30155484
http://dx.doi.org/10.1155/2018/9282646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098874/
https://www.ncbi.nlm.nih.gov/pubmed/30155484
http://dx.doi.org/10.1155/2018/9282646

Ejemplares similares